Patrick Foong
A class action suit against an Australian IVF provider is a reminder that IVF is a huge industry
Patrick Foong | 4 Feb 2021 |
Will Danielle Bopping be the Erin Brockovich of assisted reproduction?
The California Institute for Regenerative Medicine gets a second lease on life
Patrick Foong | 13 Dec 2020 |
Voters approve Prop 14
Regenerative clinics: strong language from FDA
Patrick Foong | 8 Aug 2020 |
American regulators get tough
Covid-19: should we deliberately infect volunteers?
Patrick Foong | 2 Aug 2020 |
A thorny question for researchers and ethicists
Unscrupulous scammers are selling stem cell therapies for Covid-19
Patrick Foong | 14 Jun 2020 |
Regulatory agencies need to be tough
Ethical issues surrounding egg donation in genome editing
Patrick Foong | 11 Jan 2020 |
tags:
Women need adequate counselling
How should chimeric embryo research be regulated?
Patrick Foong | 25 Aug 2019 |
Amazingly, recent experiments fall between regulatory stools in Australia
Fertility tourism: Australians travelling to US to have ‘designer babies’
Patrick Foong | 8 Jun 2019 |
It could become legal in Australia within a few years
The brave new world of human genome editing: an Australian perspective
Patrick Foong | 4 Feb 2019 |
Australian law needs to catch up with scientific developments
‘Right to try’ bills passed in US Congress: more harm than good?
Patrick Foong | 14 Apr 2018 |
The FDA has a real role to play and should not be sidelined
Untested stem cell therapies finally drawing attention of Australian regulators
Patrick Foong | 24 Nov 2017 |
There has already been one death in a clinic
|